US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 0.950
  • +0.070+7.98%
Trading Jan 21 13:35 ET
37.58MMarket Cap-2.57P/E (TTM)

About MiNK Therapeutics Company

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

Company Profile

SymbolINKT
Company NameMiNK Therapeutics
Listing DateOct 15, 2021
Issue Price12.00
Founded2017
CEODr. Jennifer S. Buell, PhD
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address149 5th Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8250

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jennifer S. Buell, PhD
  • President, Chief Executive Officer and Director
  • 2.81M
  • Christine M. Klaskin
  • Treasurer, Principal Financial Officer and Principal Accounting Officer
  • 29.62K
  • Dr. Garo H. Armen, PhD
  • Chairman of the Board
  • 344.32K
  • Dr. Robert Kadlec
  • Director
  • --
  • Brian J. Corvese
  • Independent Director
  • 154.75K
  • Ulf Wiinberg
  • Independent Director
  • 106.95K
  • Barbara Ryan
  • Independent Director
  • 154.25K
  • Peter Behner
  • Independent Director
  • 111.45K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.